The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

National Health Investors Inc

NYSE: NHI
Last

(U.S.) $54.16

Today's change-0.94 -1.71%
Updated September 1 12:21 PM EDT. Delayed by at least 15 minutes.
 

National Health Investors Inc

NYSE: NHI
Last

(U.S.) $54.16

Today's change-0.94 -1.71%
Updated September 1 12:21 PM EDT. Delayed by at least 15 minutes.

National Health Investors Inc down (U.S.)$0.94

National Health Investors Inc is sharply lower today, dropping (U.S.)$0.94 or 1.71% to (U.S.)$54.16. Over the last five days, shares have lost 1.28% and are down 22.58% for the last year to date. This security has underperformed the S&P 500 by 12.47% during the last year.

Key company metrics

  • Open(U.S.) $54.49
  • Previous close(U.S.) $55.10
  • High(U.S.) $55.03
  • Low(U.S.) $54.16
  • Bid / Ask(U.S.) $54.10 / (U.S.) $54.18
  • YTD % change-22.58%
  • Volume142,525
  • Average volume (10-day)273,479
  • Average volume (1-month)337,821
  • Average volume (3-month)227,760
  • 52-week range(U.S.) $54.16 to (U.S.) $76.98
  • Beta0.72
  • Trailing P/E17.02×
  • P/E 1 year forward16.48×
  • Forward PEG2.58×
  • Indicated annual dividend(U.S.) $3.40
  • Dividend yield6.28%
  • Trailing EPS(U.S.) $3.18
Updated September 1 12:21 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+56.94%

Based on its net profit margin of 56.94%, National Health Investors Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.15%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue56564644
Total other revenue--------
Total revenue56564644
Gross profit--------
Total cost of revenue--------
Total operating expense24261719
Selling / general / administrative3422
Research & development--------
Depreciation / amortization13131010
Interest expense (income), net operating9867
Unusual expense (income)0--00
Other operating expenses, total--------
Operating income32302826
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax32302826
Income after tax32302826
Income tax, total----00
Net income31302825
Total adjustments to net income--------
Net income before extra. items31302825
Minority interest00-10
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items31302825
Inc. avail. to common incl. extra. items31302825
Diluted net income31302825
Dilution adjustment--000
Diluted weighted average shares38383433
Diluted EPS excluding extraordinary itemsvalue per share0.830.790.800.76
Dividends per sharevalue per share0.850.850.770.77
Diluted normalized EPSvalue per share0.820.790.800.76